Followers | 43 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Saturday, October 16, 2021 12:16:09 PM
NOTE 12 – STOCKHOLDERS’ EQUITY (continued)
Common stock
The Company had authorized 1,000,000,000 shares of Common Stock at a par value of $0.00001.
During the six months ended June 30, 2021, the Company issued a total of 7,859,090 shares of common stock as follows:
• Total of 7,500,000 shares under advisory agreements (ref Note 10);
• Total of 16,666,667 shares under Data delivery and service agreements (ref Note 9)
• 1,500,000 shares under the Membership share acquisition agreement (ref Note 7);
• 250,000 shares under a business acquisition agreement (ref Note 8);
• 1,700,000 shares issued for marketing services. The Company valued the shares at the closing price of the Company’s stock as
traded on the OTCMarket on the issuance date and recorded $206,300 as stock-based compensation expense.
• Total of 60,000,000 shares under Consulting agreements (ref Note 6). These shares were issued subsequent to June 30, 2021
but were administratively issued and reported in the period ended June 30, 2021.
As of June 30, 2021, and December 31, 2019, there were 559,338,208 and 446,721,541 shares of common stock issued and outstanding, respectively.
NOTE 13 – STOCK OPTIONS
Description of 2020 Stock Option and Stock Award Plan
The Company has 50,000,000 shares available for issuance under the 2020 Stock Option and Stock Award plan. The Company has outstanding unexercised stock option grants totaling 10,000,000 shares at an exercise price of $0.05 per share as of December 31, 2020.“
https://www.otcmarkets.com/otcapi/company/financial-report/306022/content
A one billion share day or two would cleanse these share agreements off the company books. Bitcoin going to 61,000 helps because that money will want to be reinvested in tangible assets, crypto profits to work in the real world. All imo.
my posts are always theory and not financial advice
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM